Skip to content
value.today
LifeVantage Corporation logo

LifeVantage Corporation

LFVN
$74 Mmarket cap on Oct 30, 2026-0.6% since Jan 2024
Compare
World rank
#19,889
Revenue
$183 M
For year ending June-2026
Net income
$5 M
2.8% margin
SEC filing
Employees
—

LifeVantage Corporation in brief

LifeVantage Corporation is a listed company in the Package Foods industry, based in Lehi, Utah, USA. It was founded in 1988. Its market value was $74 M on 30 October 2026, which makes it the 19,889th largest listed company in the world and the 3,689th largest in the USA on this site. In the year to June 2026 it had sales of $183 M and a net profit of $5 M, about 3 cents of profit for every dollar of sales. Terrence Moorehead is its chief executive. Its largest product and service lines by sales in 2026 were Protandim® product line (45%), TrueScience® product line (21%) and LifeVantage® product line (18%). By market, the largest shares of its 2026 sales came from USA (74%) and Japan (13%). Its shares trade under the symbol LFVN (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About LifeVantage Corporation

Protandim is a herbal dietary supplement marketed with unsupported claims that it can treat a number of medical conditions. The product is a patented mix of five herbal ingredients and sold by LifeVantage Corporation (formerly LifeLine Therapeutics, Lifeline Nutraceuticals, and Yaak River Resources, Inc), a Utah-based multi-level marketing company. The manufacturers of Protandim make no claims that it can prevent or cure any medical conditions. In 2017, LifeVantage was issued a warning letter by the U.S. Food and Drug Administration (FDA) regarding illegal advertising claims on the company's websites suggesting that Protandim can help to cure various ailments, including cancer and diabetes.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

LifeVantage Corporation timeline

7 events, 1996–2021
  1. 1996
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2003
  4. 🏁
    · approximate
    Founded
  5. 2004
  6. ✎
    Renamed Lifeline Therapeutics, Inc.
    Formerly Yaak River Resources Inc.
  7. 2006
  8. ✎
    Renamed Lifevantage Corp
    Formerly Lifeline Therapeutics, Inc..
  9. 2007
  10. 🔔
    · approximate
    Initial public offering on Nasdaq as LFVN
  11. 2020
  12. 💰
    Record revenue of $233 million
    FY2020, the highest of the 9 years on record.
  13. 2021
  14. 💰
    Record net income of $13 million
    FY2021, the highest profit of the 9 years on record.

Events of LifeVantage Corporation from SEC EDGAR, Wikidata and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$59 M$117 M$176 M$234 M2020202120222023202420252026

World rank over time

▼ down 4,426 places since 2020
2020-01-01: #15511#15,51120202021-01-01: #17118#17,11820212022-01-07: #23349#23,34920222022-12-25: #25492#25,49220222023-07-30: #23760#23,76020232024-01-05: #23056#23,05620242026-03-08: #10663#10,66320262026-08-01: #17951#17,95120262026-10-14: #19918#19,91820262026-10-30: #19937#19,9372026

Rank in USA: #3,171 (Jan 2020) · #3,514 (Jan 2021) · #4,518 (Jan 2022) · #4,836 (Dec 2022) · #4,538 (Jul 2023) · #3,884 (Jan 2024) · #2,083 (Mar 2026) · #3,526 (Aug 2026) · #3,656 (Oct 2026) · #3,693 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
27.1×
Price / sales (TTM)
0.4×
Price / book
2.2×
Free cash flow yield
9.1%
Net margin (TTM)
1.6%
Operating margin
3.3%
Return on equity
8.1%
Liabilities / assets
45.9%
Net debt
$-19M
Payout ratio
46.3%
Revenue growth
-20.1%
R&D / revenue
0.5%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Jun 2019: revenue $226M, net income $7M$226MFY19Fiscal year ending Jun 2020: revenue $233M, net income $12M$233MFY20Fiscal year ending Jun 2021: revenue $220M, net income $13M$220MFY21Fiscal year ending Jun 2022: revenue $206M, net income $3M$206MFY22Fiscal year ending Jun 2023: revenue $213M, net income $3M$213MFY23Fiscal year ending Jun 2024: revenue $200M, net income $3M$200MFY24Fiscal year ending Jun 2025: revenue $229M, net income $10M$229MFY25Fiscal year ending Jun 2026: revenue $183M, net income $5M$183MFY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Jun 2026$183M-20.1%$6M$5M2.8%
Jun 2025$229M+14.2%$12M$10M4.3%
Jun 2024$200M-6.2%$4M$3M1.5%
Jun 2023$213M+3.4%$4M$3M1.2%
Jun 2022$206M-6.3%$8M$3M1.5%
Jun 2021$220M-5.5%$18M$13M5.9%
Jun 2020$233M+3.1%$15M$12M5.0%
Jun 2019$226M—$10M$7M3.3%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Jun 2026$10M$4M$7M$0.40$0.18
Jun 2025$12M$1M$11M$0.75$0.17
Jun 2024$12M$2M$10M$0.23$0.55
Jun 2023$7M$3M$4M$0.20$0.13
Jun 2022$8M$2M$6M$0.24$0.03
Jun 2021$16M$4M$13M$0.90—
Jun 2020$18M$3M$16M$0.79—
Jun 2019$18M$3M$15M$0.50—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$172M
Net income, trailing 12 months
$3M
RevenueNet income
Three months to Dec 2024: revenue $68M, net income $3M$68MDec ’24Three months to Mar 2025: revenue $58M, net income $3M$58MMar ’25Three months to Jun 2025 (from the annual report): revenue $55M, net income $2M$55MJun ’25Three months to Sep 2025: revenue $48M, net income $2M$48MSep ’25Three months to Dec 2025: revenue $49M, net income $0M$49MDec ’25Three months to Mar 2026: revenue $44M, net income $1M$44MMar ’26Three months to Jun 2026 (from the annual report): revenue $42M, net income $1M$42MJun ’26Three months to Sep 2026: revenue $37M, net income $-0M$37MSep ’26

Latest quarter to Sep 2026: revenue $37M (-22.0% on a year earlier), net income $-0M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of LifeVantage Corporation with the US Securities and Exchange Commission.

Annual results

Revenue
$183 M
Operating income
$6 M
Net income
$5 M

For year ending June-2026 · source: SEC filing

Balance sheet

Total assets
$62 M
Total liabilities
$29 M
Total equity
$34 M

As of June-2026

Top 80 institutional investors in LifeVantage Corporation#

As of Sep 30, 2026
80 institutions held 5.8 M shares (about 46.3% of the shares outstanding) on Sep 30, 2026. The ten largest hold 37.6%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in LifeVantage Corporation
#InstitutionShares heldChange (shares)% heldValueFiled
1Capital Management Corp /va2,307,489+429,078 (+22.84%)18.42%$15 MOct 29, 2026
2Renaissance Technologies LLC630,218-39,200 (-5.86%)5.03%$4 MNov 12, 2026
3Vanguard Capital Management LLC445,333+16,130 (+3.76%)3.55%$3 MNov 13, 2026
4American Century Companies Inc257,226+112,840 (+78.15%)2.05%$2 MNov 12, 2026
5BlackRock, Inc.255,896-12,709 (-4.73%)2.04%$2 MNov 13, 2026
6Dimensional Fund Advisors LP239,366-16,930 (-6.61%)1.91%$2 MNov 4, 2026
7Envestnet Asset Management Inc232,821+2,914 (+1.27%)1.86%$1 MNov 16, 2026
8Geode Capital Management, LLC123,129+2,299 (+1.90%)0.98%$1 MNov 6, 2026
9Goldman Sachs Group Inc121,720+10,856 (+9.79%)0.97%$1 MNov 16, 2026
10Advyzon Investment Management, LLC100,678+14,851 (+17.30%)0.80%$1 MNov 16, 2026
11Indivisible Partners98,842+14,657 (+17.41%)0.79%$1 MOct 26, 2026
12Perkins Capital Management Inc77,708+2,250 (+2.98%)0.62%$0 MNov 2, 2026
13Vanguard Fiduciary Trust Co64,2380 (0.00%)0.51%$0 MNov 13, 2026
14Barclays PLC64,196-705 (-1.09%)0.51%$0 MNov 6, 2026
15Susquehanna International Group, LLP63,839-105,207 (-62.24%)0.51%$0 MNov 16, 2026
16Morgan Stanley53,918-11,366 (-17.41%)0.43%$0 MNov 13, 2026
17State Street Corp49,091-3,500 (-6.66%)0.39%$0 MNov 12, 2026
18Citadel Advisors LLC47,200-52,591 (-52.70%)0.38%$0 MNov 16, 2026
19BNP Paribas Financial Markets43,918-4,895 (-10.03%)0.35%$0 MNov 12, 2026
20FMR LLC42,034+34,524 (+459.71%)0.34%$0 MNov 10, 2026
21&partners36,168+3,043 (+9.19%)0.29%$0 MNov 16, 2026
22Jane Street Group, LLC35,517-102,539 (-74.27%)0.28%$0 MNov 12, 2026
23Bank of New York Mellon Corp35,438+23,002 (+184.96%)0.28%$0 MNov 5, 2026
24Millennium Management LLC33,436-36,888 (-52.45%)0.27%$0 MNov 16, 2026
25State of Alaska, Department of Revenue27,6640 (0.00%)0.22%$0 MOct 15, 2026
Show all 80: investors 26 to 80
Institutional investors 26 to 80 in LifeVantage Corporation
#InstitutionShares heldChange (shares)% heldValueFiled
26Northern Trust Corp24,428-550 (-2.20%)0.20%$0 MNov 16, 2026
27Cetera Investment Advisers24,354-5,065 (-17.22%)0.19%$0 MNov 13, 2026
28Bridgeway Capital Management, LLC23,5240 (0.00%)0.19%$0 MNov 16, 2026
29Empowered Funds, LLC23,5240 (0.00%)0.19%$0 MNov 13, 2026
30AQR Capital Management LLC19,782-93,421 (-82.53%)0.16%$0 MNov 16, 2026
31LPL Financial LLC19,361-14,668 (-43.10%)0.15%$0 MNov 6, 2026
32Qube Research & Technologies Ltd16,552-37,594 (-69.43%)0.13%$0 MNov 13, 2026
33MML Investors Services, LLC14,5000 (0.00%)0.12%$0 MNov 13, 2026
34Simplicity Wealth,LLC14,500New0.12%$0 MOct 23, 2026
35Hantz Financial Services, Inc.13,5020 (0.00%)0.11%$0 MNov 9, 2026
36Raymond James Financial Inc13,408New0.11%$0 MNov 12, 2026
37Engineers Gate Manager LP13,255-13,754 (-50.92%)0.11%$0 MNov 16, 2026
38Callan Family Office, LLC13,0970 (0.00%)0.10%$0 MNov 13, 2026
39Price T Rowe Associates Inc /MD/12,9000 (0.00%)0.10%$0 MNov 16, 2026
40New England Professional Planning Group Inc.11,751+93 (+0.80%)0.09%$0 MOct 29, 2026
41UBS Group AG10,204+4,459 (+77.62%)0.08%$0 MNov 10, 2026
42Russell Investments Group, Ltd.4,849-1,500 (-23.63%)0.04%$0 MNov 6, 2026
43TD Waterhouse Canada Inc.3,2700 (0.00%)0.03%$0 MOct 16, 2026
44Jpmorgan Chase & Co3,262+3,150 (+2812.50%)0.03%$0 MNov 12, 2026
45Nuveen, LLC3,158New0.03%$0 MNov 10, 2026
46Vanguard Global Advisers, LLC3,0290 (0.00%)0.02%$0 MNov 13, 2026
47Arax Advisory Partners2,684-1,808 (-40.25%)0.02%$0 MNov 12, 2026
48Jones Financial Companies Lllp2,456-85 (-3.35%)0.02%$0 MNov 13, 2026
49Simplex Trading, LLC2,424-14,029 (-85.27%)0.02%$0 MNov 4, 2026
50Blue Trust, Inc.1,6860 (0.00%)0.01%$0 MOct 15, 2026
51GAMMA Investing LLC1,440-38 (-2.57%)0.01%$0 MOct 8, 2026
52Wells Fargo & Company/mn1,4280 (0.00%)0.01%$0 MNov 16, 2026
53PNC Financial Services Group, Inc.1,278-38 (-2.89%)0.01%$0 MNov 6, 2026
54Physician Wealth Advisors, Inc.1,1850 (0.00%)0.01%$0 MOct 20, 2026
55SBI Securities Co., Ltd.1,070+99 (+10.20%)0.01%$0 MOct 22, 2026
56Royal Bank Of Canada957-3,811 (-79.93%)0.01%$0 MNov 16, 2026
57Citigroup Inc882-5,177 (-85.44%)0.01%$0 MNov 4, 2026
58Osaic Holdings, Inc.832-227 (-21.44%)0.01%$0 MNov 12, 2026
59Group One Trading LLC714New0.01%$0 MNov 10, 2026
60Burk Holdings LLC485+4 (+0.83%)0.00%$0 MNov 5, 2026
61UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC407New0.00%$0 MNov 16, 2026
62Harbour Investments, Inc.3750 (0.00%)0.00%$0 MNov 9, 2026
63Pinnacle Wealth Planning Services, Inc.3300 (0.00%)0.00%$0 MOct 27, 2026
64Optiver Holding B.V.288New0.00%$0 MNov 16, 2026
65Parallel Advisors, LLC2000 (0.00%)0.00%$0 MNov 3, 2026
66Ameritas Advisory Services, LLC2000 (0.00%)0.00%$0 MNov 12, 2026
67RHL Group, LLC128+1 (+0.79%)0.00%$0 MNov 4, 2026
68NewEdge Advisors, LLC1080 (0.00%)0.00%$0 MNov 13, 2026
69IFG Advisory, LLC1000 (0.00%)0.00%$0 MNov 9, 2026
70Caitong International Asset Management Co., Ltd66-121 (-64.71%)0.00%$0 MOct 29, 2026
71EverSource Wealth Advisors, LLC47-243 (-83.79%)0.00%$0 MNov 4, 2026
72Rockefeller Capital Management L.P.45New0.00%$0 MNov 13, 2026
73Allworth Financial LP39-199 (-83.61%)0.00%$0 MNov 17, 2026
74IFP Advisors, Inc30-44 (-59.46%)0.00%$0 MOct 16, 2026
75Kozak & Associates, Inc.250 (0.00%)0.00%$0 MOct 29, 2026
76SJS Investment Consulting Inc.17-56 (-76.71%)0.00%$0 MOct 26, 2026
77Essential Partners LLC7-65 (-90.28%)0.00%$0 MOct 14, 2026
78Rothschild Investment LLC6-38 (-86.36%)0.00%$0 MNov 10, 2026
79Root Financial Partners, LLC1New0.00%$0 MOct 21, 2026
80Strive Financial Group ,LLC10 (0.00%)0.00%$0 MNov 9, 2026

Mutual funds holding LifeVantage Corporation#

43 funds hold shares worth $7 M (about 8.6% of the company). Since their previous reports 9 added shares and 40 sold, selling $3 M net.
Mutual funds holding LifeVantage Corporation
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.307,743$2 M2.5%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.110,659$1 M0.88%<0.01%−0.2%Jun 30, 2026
🇺🇸 Avantis U.S. Small Cap Value ETFAmerican Century ETF Trust77,413$1 M0.62%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC73,531$1 M0.59%<0.01%+36%May 31, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP72,727$0 M0.58%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.54,154$0 M0.43%<0.01%+2.1%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors36,603$0 M0.29%0.02%+35%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.32,577$0 M0.26%<0.01%+372%Jun 30, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP28,996$0 M0.23%<0.01%−9.0%Jul 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP26,845$0 M0.21%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC18,690$0 M0.15%<0.01%no changeMay 31, 2026
🇺🇸 EA Bridgeway Omni Small-Cap Value ETFEmpowered Funds, LLC d/b/a EA Advisers23,524$0 M0.19%0.01%no changeJun 30, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP21,105$0 M0.17%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC16,878$0 M0.13%<0.01%+8.0%May 31, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust16,662$0 M0.13%<0.01%−12%May 31, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.16,349$0 M0.13%0.01%+1.4%May 31, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP16,797$0 M0.13%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP13,233$0 M0.11%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.10,261$0 M0.08%<0.01%+3.0%May 31, 2026
🇺🇸 T. Rowe Price Extended Equity Market Index FundT. Rowe Price Associates, Inc.12,900$0 M0.10%<0.01%no changeJun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC9,383$0 M0.07%<0.01%no changeMay 31, 2026
🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP11,327$0 M0.09%<0.01%no changeJul 31, 2026
🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC8,847$0 M0.07%<0.01%−64%Jul 31, 2026
🇺🇸 Avantis U.S. Equity ETFAmerican Century ETF Trust6,080$0 M0.05%<0.01%no changeMay 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.7,299$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP7,128$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.6,557$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company4,303$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.4,244$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 LVIP Dimensional U.S. Core Equity 2 FundLincoln Financial Investments Corporation2,676$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.2,457$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC2,436$0 M0.02%<0.01%+20%Jun 30, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP2,233$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC2,129$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity FundAmerican Century ETF Trust1,530$0 M0.01%<0.01%no changeMay 31, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC1,827$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION1,100$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.729$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC504$0 M<0.01%<0.01%+9.1%May 31, 2026
🇺🇸 Avantis U.S. Equity FundAmerican Century ETF Trust472$0 M<0.01%<0.01%−42%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC394$0 M<0.01%<0.01%−41%May 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC399$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC353$0 M<0.01%<0.01%no changeMay 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 43 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at LifeVantage Corporation#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$196 K
8 purchases, 2 insiders
Sold, 12 months
$190 K
4 sales, 2 insiders
Net, 12 months
$6 K
open market only
Insiders on file
42
since
$126 K-$365 K$0Nov 2023: bought $89 K (8 trades), sold $33 K (1 trades)Nov 23Dec 2023: bought $3 K (2 trades), sold $0 (0 trades)Feb 2024: bought $1 K (2 trades), sold $0 (0 trades)Mar 2024: bought $3 K (2 trades), sold $0 (0 trades)MarJun 2024: bought $4 K (2 trades), sold $0 (0 trades)Sep 2024: bought $15 K (7 trades), sold $0 (0 trades)Dec 2024: bought $4 K (1 trades), sold $0 (0 trades)DecFeb 2025: bought $0 (0 trades), sold $365 K (3 trades)May 2025: bought $26 K (7 trades), sold $0 (0 trades)Jun 2025: bought $5 K (2 trades), sold $0 (0 trades)JunJul 2025: bought $0 (0 trades), sold $37 K (1 trades)Sep 2025: bought $5 K (1 trades), sold $49 K (2 trades)Nov 2025: bought $0 (0 trades), sold $330 K (3 trades)NovDec 2025: bought $5 K (1 trades), sold $0 (0 trades)Feb 2026: bought $126 K (3 trades), sold $0 (0 trades)Mar 2026: bought $53 K (2 trades), sold $0 (0 trades)MarJun 2026: bought $6 K (1 trades), sold $86 K (1 trades)Sep 2026: bought $6 K (1 trades), sold $56 K (2 trades)Nov 2026: bought $0 (0 trades), sold $49 K (1 trades)Nov
Bought (open market)Sold (open market)Hover a month for the totals
LifeVantage Corporation: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Michael A. BeindorffDirectorSellindirect-10,000$4.886$49 K31,625Form 4
filed Judd DaytonDirectorGrant or award+17,888$5.870$105 K98,247Form 4
filed Raymond B. GreerDirectorGrant or award+17,888$5.870$105 K130,707Form 4
filed Rajendran AnbalaganDirectorGrant or award+17,888$5.870$105 K41,887Form 4
filed Michael A. BeindorffDirectorGrant or award+17,888$5.870$105 K45,458Form 4
filed Darwin LewisDirectorGrant or award+17,888$5.870$105 K156,132Form 4
filed Terrence MooreheadPresident and CEO, DirectorGrant or award+193,237——501,879Form 4
filed Carl AureChief Financial OfficerGrant or award+35,749——191,784Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: LifeVantage Corporation#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
906,622
7.2% of shares · 42.11 days to cover
Dividend per share, Q2 2026
$0.050
+11.1% on a year earlier
Buybacks, Q3 2026
$0M
Q1 2027
Shares sold short, last 24 reportsAll stocks →

Stock splits: 7-for-1 split

LifeVantage Corporation dividends per share by quarter
Dividend, quarterPer share
Q2 2026$0.050
Q1 2026$0.045
Q4 2025$0.045
Q3 2025$0.045
Q2 2025$0.045
Q1 2025$0.040
Q4 2024$0.040
Q3 2024$0.040
Q2 2024$0.040
Q1 2024$0.035
Q4 2023$0.035
Q3 2023$0.035
Q2 2023$0.035from the annual figure
Q1 2023$0.030
Q4 2022$0.030
Q3 2022$0.030
LifeVantage Corporation share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2026Q1 2027$0M
Q2 2026Q4 2026$0.5M
Q1 2026Q3 2026$1M
Q3 2025Q1 2026$0.6M
Q2 2025Q4 2025$2M
Q1 2025Q3 2025$0M
Q4 2024Q2 2025$0M
Q3 2024Q1 2025$1.1M
Q2 2024Q4 2024$1.8M
Q1 2024Q3 2024$1.9M
Q4 2023Q2 2024$1.9M
Q3 2023Q1 2024$0.8M
Q2 2023Q4 2023$0.8M
Q1 2023Q2 2023$0M
Q4 2022Q2 2023$0M
Q3 2022Q1 2023$0M

Trading halts

  • 2026-06-10 13:46 UTC, code LUDP, resumed 13:51 UTC
  • 2026-06-10 13:30 UTC, code LUDP, resumed 13:45 UTC
  • 2025-02-06 14:32 UTC, code LUDP, resumed 14:37 UTC

Fails to deliver

  • : 246 shares at $5.87
  • : 866 shares at $5.98
  • : 194 shares at $5.95
  • : 565 shares at $5.97
  • : 607 shares at $6.00

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

LifeVantage Corporation scorecard#

Passes 13 of the 25 checks that could be worked out: strongest in financial health (3 of 3), weakest in growth (0 of 6). Fiscal year 2026; market cap of Oct 30, 2026.

  • Valuation2 of 6
    • ✗P/E below its peers' median27.1×P/E 27.1× against Package Foods's median of 23.9×.
    • ✗Price to book below its peers' median2.2×Price to book 2.2× against Package Foods's median of 2.2×.
    • ✓Price to sales below its peers' median0.4×Price to sales 0.4× against Package Foods's median of 1.0×.
    • ✓Free cash flow yield above 5%9.1%Free cash flow is 9.1% of the market value.
    • ✗Earnings yield above the 10-year Treasury yield3.7%Earnings yield 3.7% against the 10-year Treasury's 5.15% on 2026-11-13.
    • ✗The price assumes slower growth than the last three years'-4.6%The price assumes -4.6% a year for ten years; revenue grew -5.1% a year over the last three.
  • Growth0 of 6
    • ✗Revenue grew in the newest year-20.1%Revenue down 20.1% in fiscal 2026.
    • ✗Revenue up more than 5% a year over three years-5.1%-5.1% a year over the three years to fiscal 2026.
    • ✗Faster growth over three years than its peers' median-5.1%-5.1% a year against Package Foods's median of 1.4% (48 companies).
    • ✗Earnings per share grew in the newest year0.40 vs 0.75Diluted EPS 0.40 in fiscal 2026 against 0.75 the year before (report's currency).
    • ✗Net income higher than five years earlier$5 M$5 M in fiscal 2026 against $13 M in 2021.
    • ✗Revenue rose in at least four of the last five years2 of 5Revenue rose in 2 of the five years to fiscal 2026.
  • Profitability3 of 5
    • ✓Profitable in the newest year$5 MNet income $5 M in fiscal 2026.
    • ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2026.
    • ✗Operating margin above its peers' median3.3%3.3% against Package Foods's median of 5.3% (76 companies).
    • ✗Return on equity above 15%14.9%14.9% in fiscal 2026.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier3.3%3.3% in fiscal 2026 against 2.0% in 2023.
  • Financial health3 of 3
    • ✓Short-term assets cover short-term liabilities1.9×Current ratio 1.89 at the end of fiscal 2026.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2026.
    • ✓Altman Z-score outside the distress zone2.83Z-score 2.83 (grey zone) for fiscal 2026.
  • Shareholder returns5 of 5
    • ✓Pays a dividendYesPaid dividends in fiscal 2026.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • ✓Dividends under 75% of net income46.1%Dividends were 46.1% of net income in fiscal 2026.
    • ✓Share count up no more than 2% in a year-2.2%Diluted shares down 2.2% in fiscal 2026.
    • ✓Dividends and buybacks above 3% of the market value6.0%Dividends and buybacks were 6.0% of the market value.
    • ✓Free cash flow covers dividends and buybacks$7 MFree cash flow $7 M against $4 M paid out in fiscal 2026.

Worked out from the statements as filed (sec), the medians of Package Foods, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2026#

Worked out from LifeVantage Corporation's statements, beside the median of Package Foods.

LifeVantage Corporation: main financial ratios in 2026
Ratio2026Median of peers
Operating margin3.3%5.3%
Net margin2.8%4.1%
Return on equity14.9%9.2%
Revenue growth, 3 years a year-5.1%1.4%
Revenue growth-20.1%3.0%
Free cash flow margin3.7%4.4%

4of 8on the Piotroski tests of financial strength

  • Revenue fell 20.1% against the year before.
  • Free cash flow has been positive 16 years in a row.
  • The share count fell 2.2% in the year (buybacks).

LifeVantage Corporation: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

LifeVantage Corporation: statements by fiscal year
PeriodTrendFY 2026to Jun 30, 2026FY 2025to Jun 30, 2025FY 2024to Jun 30, 2024FY 2023to Jun 30, 2023FY 2022to Jun 30, 2022FY 2021to Jun 30, 2021FY 2020to Jun 30, 2020FY 2019to Jun 30, 2019FY 2018to Jun 30, 2018FY 2017to Jun 30, 2017
Income statement
Revenue183229200213206220233226203199
Cost of revenue41454143383838383533
Gross profit142184159170168182195188168166
Research and development1.01.40.70.60.70.70.91.11.21.1
Selling, general and administrative58696871636168706065
Operating expenses136171154166161164179178158162
Operating income6.1124.34.37.618159.8104.4
Interest expense and finance costs——−0.4−0.20.00.00.10.30.50.6
Other non-operating income (expense)−0.00.00.0−0.3−2.9−0.4−0.8−0.6−0.8−1.5
Income before tax6.1124.44.04.717159.29.52.9
Income tax1.02.41.41.51.64.33.11.83.81.3
Net income attributable to shareholders5.19.82.92.53.113127.45.81.6
Earnings per share, basic0.400.800.240.200.240.920.820.530.410.12
Earnings per share, diluted0.400.750.230.200.240.900.790.500.410.11
Shares, weighted average (basic)13121213131414141414
Shares, weighted average (diluted)13131313131415151414
Dividends per share0.190.170.550.130.03—————
Balance sheet
Cash and cash equivalents15201722202322191711
Receivables3.03.32.91.63.32.92.62.12.11.3
Inventory16211516161614141417
Other current assets2.86.12.44.85.24.85.27.36.15.3
Current assets38513844474844433936
Property, plant and equipment7.36.27.89.19.5117.27.16.63.1
Right-of-use (leased) assets6.78.09.68.711141.00——
Goodwill0.50————————
Other intangible assets3.10.20.30.50.60.70.91.01.11.2
Long-term investments—————2.22.2———
Total assets62726066717959555145
Accounts payable5.24.65.93.57.56.73.55.23.84.9
Debt due within a year——————01.52.02.0
Current liabilities20272220262525262423
Long-term debt———————03.45.4
Lease liabilities (non-current)7.99.8121213160———
Total liabilities29373431394226282931
Retained earnings−103−104−109−98−98−92−93−100−103−107
Shareholders' equity3435263532373327r22r15
Total liabilities and equity62726066717959555145
Shares outstanding13121313121414141414
Cash-flow statement
Depreciation and amortization2.83.23.63.63.33.52.81.91.31.6
Share-based compensation2.35.73.33.21.82.04.95.53.22.6
Cash from operating activities1012126.88.0161818136.6
Capital expenditure−3.6−1.4−2.2−3.1−1.5−3.7−2.7−2.5−4.6−1.1
Cash from investing activities−7.3−1.4−2.2−3.1−1.5−3.7−2.7−4.5−4.6−1.1
Debt issued————————00
Debt repaid————00−1.5−4.0−2.0−2.0
Shares bought back−2.0−3.1−6.4−0.8−8.8−12−5.4−4.7−1.50
Dividends paid−2.3−2.1−6.9−1.6−0.400———
Cash from financing activities−7.8−7.6−14−2.4−9.0−11−12−11−3.5−2.0
Exchange-rate effect on cash−0.40.4−0.30.0−0.5−0.10.10.00.1−0.0
Change in cash−5.33.3−4.71.4−3.01.03.32.25.23.6
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What LifeVantage Corporation sells: revenue by product line, fiscal 2026#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2025. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Protandim® product line$82 M45%
  • TrueScience® product line$38 M21%
  • LifeVantage® product line$32 M18%
  • AXIO® product line$15 M8.2%
  • LoveBiome Product Line$9 M5.0%
  • Other$4 M2.4%
  • PhysIQ™ product line$4 M2.1%
  • Petandim® product line$2 M1.1%

Business segments

  • Reportable$183 M100%

Countries and regions

Source: SEC annual report (XBRL data) · as of Jun 30, 2026

Where LifeVantage Corporation operates: 15 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 17 subsidiaries on file.

LifeVantage Corporation: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters2 offices1 subsidiary$135 M74%
🇲🇽 Mexico2 subsidiaries—
🇸🇬 Singapore2 subsidiaries—
🇦🇺 Australia1 subsidiary—
🇨🇦 Canada1 subsidiary—
🇨🇳 China1 subsidiary—
🇭🇰 Hong Kong1 subsidiary—
🇲🇾 Malaysia1 subsidiary—
🇳🇱 Netherlands1 subsidiary—
🇳🇿 New Zealand1 subsidiary—
🇵🇭 Philippines1 subsidiary—
🇹🇼 Taiwan1 subsidiary—
🇹🇭 Thailand1 subsidiary—
🇬🇧 UK1 subsidiary—
🇯🇵 Japan1 subsidiary$24 M13%

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at LifeVantage Corporation#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2026
$2.2 M
Terrence Moorehead
Other top executives, average
$786 K
the CEO earned 2.8× this
$100 invested is now
$49
LifeVantage Corporation: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2026Terrence Moorehead$2.2 M−$219 K$786 K$49
2025Steven R. Fife$2.8 M$7.5 M$1.0 M$206
2024Steven R. Fife$2.3 M$3.0 M$704 K$160

Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2026

Events at LifeVantage Corporation#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 6 · Material agreement 2 · New debt 1 · Shareholder rights changed 1 · Bylaws or fiscal year changed 2 · Shareholder vote 5 · Results announced 12

LifeVantage Corporation: events reported to the SEC
FiledWhat happenedFiling
Shareholder vote8-K
Results announced8-K
Bylaws or fiscal year changed8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Directors and officersResults announced8-K
Directors and officers8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Shareholder rights changedBylaws or fiscal year changed8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Material agreementNew debt8-K
Directors and officersMaterial agreement8-K
Results announced8-K
Shareholder vote8-K/A
Shareholder vote8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026

Acquisitions and funding#

1 acquisitions, $4 M paid where reported · 3 private funding rounds before listing

Businesses it acquired

Acquisitions by LifeVantage Corporation
AcquiredAcquisition dateCompletionPriceStakeSource
LoveBiome2025—$4 M—Annual report

Private share sales · funding history

Private share sales of LifeVantage Corporation
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2009$3 MNo. 3$2 to $10 million56debt, optionsSEC
Jun 2009$2 MNo. 2Under $2 million34equity, optionsSEC
Mar 2009$4 MNo. 1$2 to $10 million93equity, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at LifeVantage Corporation#

1 labor condition applications certified in fiscal 2024 for 1 positions, at a median wage of $160 K a year.

Certified, FY2024
1
#1,966 among companies on value.today
Worker positions
1
Median wage offered
$160 K
a year, full-time
Applications filed
1
LifeVantage Corporation: most frequent H-1B job titles in fiscal 2024
Job titlePositionsMedian wage offered
Sr. Director Digital Product- Consultant ToolsOperations Research Analysts1$160 K

Where: Lehi, UT 1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as LifeVantage Corporation

How LifeVantage Corporation compares in Package Foods

  • Market cap$74 M · higher than 19% of 259
  • Revenue$183 M · higher than 15% of 253
  • Net margin1.6% · higher than 19% of 247
  • Revenue growth-20.1% · higher than 7% of 92
  • P/E ratio27.1× · lower than 28% of 147
  • Price / sales0.4× · lower than 84% of 167
  • Price / book2.2× · lower than 42% of 155
  • FCF yield9.1% · higher than 71% of 56

Peer comparison · Package Foods

CompanyMarket capP/ENet marginRev. growth
LifeVantage Corporation🇺🇸$74 M27.1×1.6%-20.1%
Nestlé S.A.🇨🇭$256.1 B22.4×10.1%+3.8%
Danone S.A.🇨🇭$50.1 B23.2×6.7%-0.8%
Ajinomoto Co., Inc.🇯🇵$33.5 B36.7×8.5%—
Foshan Haitian Flavouring and Food Company Ltd.🇨🇳$30.5 B29.9×24.4%—
The Kraft Heinz Company🇺🇸$28.3 B—-14.0%-3.5%
Nestle India Limited🇮🇳$26.9 B———
Inner Mongolia Yili Industrial Group Co., Ltd.🇨🇳$23.9 B14.3×10.0%—
Yihai Kerry Arawana Holdings Co., Ltd🇨🇳$21.0 B46.0×1.3%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending June-2026
Balance sheet:
As of June-2026
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, Wikipedia, Wikimedia Commons; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at LifeVantage Corporation? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show LifeVantage Corporation's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about LifeVantage Corporation? Suggest a correction